Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Psychopharmacology (Berl). 2010 May 18;213(2-3):547–553. doi: 10.1007/s00213-010-1881-0

Fig. 1.

Fig. 1

Upper panel: plot showing significant differences in ventral striatum/ventral pallidum (VS/VP) region of interest [11C]P943 binding potential (BPND) between patients with major depressive disorder (MDD) and healthy control subjects (HC). Lower panel: average [11C]P943 BPND co-registered positron emission tomography images illustrate reduced VS/VP [11C]P943 BPND in MDD (right) relative to HC (left)